{"ticker": {"uuid": "8780f85d-bb8f-45c3-98f7-68c705260be8", "symbol": "3692", "name": "Hansoh Pharmaceutical Group Company Limited", "exchange": "HKG", "country": "HK", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Hansoh Pharma Licenses IL-23 Drug to Avere and Gains Major Stake in Nasdaq-Bound Merger", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxOZUMyWkJJcWN2WmNtTzZPT0MybEFHRWRSY0VDNEpIaG5MZmZDcUY4ZlB5OEM0OWtFZTktNy1hS0g2cmJQQ1hGNGtMdzNTTEFBeDNkek5NTTRhOE5sMldXeUFPMGFCUFdkaFdZRUlRaV95UFQySWRhWHdXaXZXVV9KOHByZ2ItSUQtZ1piYlEteEJUYUxsVkFPYmctRTRPOUw0RVR1WFhTdTFhbFh1S1hGWkw4TWxYQkxxWEcyV0poY3BhVklzbVotVVl0a3FNd0ZDNDJNWjVn?oc=5", "source_name": "TipRanks", "published_at": "2026-07-14T10:19:29+00:00", "published_display": "14 Jul 2026 10:19", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansoh Pharma\u2019s HS-20093 Meets Phase III Survival Goal in Small Cell Lung Cancer", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxPSFpYM1dOZnpyOXlFMzlPaGNSdWFYbExsZEp5eEZfaGlXVDN5Vl9UVGMtVFdKLVFSOFFDMkNEUDFoTm9kakFCc28xUHZubzl4a21KYWFkYlJuWUJKMkpEVlphc1NlLXNSOExEZU00ZVo0Q19fdm1jSV9RSko3MHJIcTlfWEl5Wk9ydndiaUpEeWV2OWp6XzdfeE1zTEt3Z1VHQ0FzMTZiUE81ZWh2QmphT3gtN0RrSzhBMUo0THljYW9abjRNc2ViT2toSQ?oc=5", "source_name": "TipRanks", "published_at": "2026-07-10T12:15:44+00:00", "published_display": "10 Jul 2026 12:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansoh Pharmaceutical Group Stock Sheds 4.2% in Hong Kong", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNYWtVZ1hFWC13dHJVNHY5ZGU0YVBVUnY4V1BsSE9lREptdHdxcWtvUkVvOG1teG1iemhfQXpjSlpLWko5dzFoMkxkSjNRYzd0SEwxcVpjdjJ1cnZleU9lalY4ZmVONDhic2c0QTFBek1kNHdOeHIwZWZ5TXJsNW1USm1SRlctUmZjT1RGYkg5M3YwWFRCSFZpSV9tZ0Faa3c?oc=5", "source_name": "Moomoo", "published_at": "2026-07-07T08:30:00+00:00", "published_display": "07 Jul 2026 08:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansoh Pharmaceutical Group (SEHK:3692) Wins Trial Approval, Is It Fully Priced?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-05T07:00:00+00:00", "published_display": "05 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Results: Hansoh Pharmaceutical Group Company Limited Beat Earnings Expectations And Analysts Now Have New Forecasts", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-AFBVV95cUxNS0ZQelVmQklyUFl2aGt3OUNWaU5CdVNSQlVheGs2TG1TWklzQ2syZlc5TUpfdmI0djZCc2hnT0U3eUROT3N1OWxEWmZYSHhRLW1maEthY19Eejdhd3pkYUNSbGctMy1KeVhEdjlpLU5VMGJ4SG9RSmpFc3BJaHhrbGJYb3cwVHQxZnVOTUM3QXpKNFZ6YmJQazFNWTJkTVAzT2JlWHhuSjlOcVV2M2dCUFVvbUNSSXk0WjI4Uzd1Y3VOTUxKNHFWaDRRNzBHVWh3TENVeUt3ZnlLendTX3JpZkxxc0tGSHFQOHhvVC1EU0hHV0htdU81RtIB_gFBVV95cUxNQThZS0kyaXR3YXRkWGY2U1M4REVCQ29HWkk5UmZWSGNfTkRBQ3ExWEhLbGQwa2xybGptcW9IVkNHMUdlaGV5OFFPa3FTT2tPcFZUVmhsVk1pRERzeDZKVVItUS1YQnFDcXpMMEhCbUZYSlg1SjRJYTd6ZUMwRFdPaXh5SlVFZGljQVhiRG1aSFVjZkpfMFR4eHVtc2xnZldEeUhQZDFWUW42UGRPdUdDVGI1QS15UkJySlg2ZGllZlhTTTBEU0RVTHlrd1RLcGxvcU0zUFRLVk9zc2MwM28zMmZQSU5jZnpoV1ZWaTFGaDc0Q19GOEZUWGFUTU5wQQ?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansoh and Leads Biolabs clinch US$2.5 billion in global drug licensing deals", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "South China Morning Post", "published_at": "2025-10-17T07:00:00+00:00", "published_display": "17 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotheus, Hansoh ink potential \u00a55B deal for new bispecific ADCs", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOcVZRRENYWF9Ld09GXzVFS1g5a0VfUHREMzhTSXp0SGVPZ3BIN2JiVjdpclFpZjdGQWh4eHZrekFzWW9FcnpwM3I0Q2VnTzUzTUNBc0hjenN1dVdOeTFtbzl3dEVYVnRqcHpTT2FyM3F3Zkg3bFNPNGVoS0tCUF9lMWY2RzR1eUhGcklRTjBGcjhBVHpfZnFhZ2NmYzRYVDhMM1U4MA?oc=5", "source_name": "BioWorld News", "published_at": "2024-03-18T07:00:00+00:00", "published_display": "18 Mar 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GSK signs $1B+ licensing deal with China\u2019s Hansoh for ADC candidate", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPTlAtN2gxQV9jaFVPZUE2R1didGFDQThMZHBzbnM2TmQ5YmhiUjNnUm15QWJ3T0N5MUgtaG5oM2ZoQXFJRHJ2NHRfMC1oTHZKMTZUdXdscW0zX1NmVFUzQVRBMmlIOEtMT1BrQ3BfX0dKdTJiM25BWU80d3FXOEhqV0JDTUZidDVYam9FRVZaejhLQXljMFFKTVZ1S2pzalBmYzVSeDhRVUg?oc=5", "source_name": "BioWorld News", "published_at": "2023-10-23T07:00:00+00:00", "published_display": "23 Oct 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hang Seng review shines light on China\u2019s 6th richest woman at Hansoh Pharma", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "South China Morning Post", "published_at": "2022-08-22T07:00:00+00:00", "published_display": "22 Aug 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of Hansoh Pharmaceutical Group Company Limited (HKEX:3692)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiaEFVX3lxTE0yaHNIOThuNmNEVnRVZmFrckg1dlQ2Q081RGxvSXdRckJkNmg0STJWZFhWTXgyeFN1aHBpUXBnZXZPc1ZINmFYNnZFOGpHUGl5SjV4V0hFMmVSSDE5UUVZY3pGYkNQakZE?oc=5", "source_name": "TradingView", "published_at": "2019-10-11T04:43:01+00:00", "published_display": "11 Oct 2019 04:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Hansoh Pharma Licenses IL-23 Drug to Avere and Gains Major Stake in Nasdaq-Bound Merger", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxOZUMyWkJJcWN2WmNtTzZPT0MybEFHRWRSY0VDNEpIaG5MZmZDcUY4ZlB5OEM0OWtFZTktNy1hS0g2cmJQQ1hGNGtMdzNTTEFBeDNkek5NTTRhOE5sMldXeUFPMGFCUFdkaFdZRUlRaV95UFQySWRhWHdXaXZXVV9KOHByZ2ItSUQtZ1piYlEteEJUYUxsVkFPYmctRTRPOUw0RVR1WFhTdTFhbFh1S1hGWkw4TWxYQkxxWEcyV0poY3BhVklzbVotVVl0a3FNd0ZDNDJNWjVn?oc=5", "source_name": "TipRanks", "published_at": "2026-07-14T10:19:29+00:00", "published_display": "14 Jul 2026 10:19", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansoh Pharma\u2019s HS-20093 Meets Phase III Survival Goal in Small Cell Lung Cancer", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxPSFpYM1dOZnpyOXlFMzlPaGNSdWFYbExsZEp5eEZfaGlXVDN5Vl9UVGMtVFdKLVFSOFFDMkNEUDFoTm9kakFCc28xUHZubzl4a21KYWFkYlJuWUJKMkpEVlphc1NlLXNSOExEZU00ZVo0Q19fdm1jSV9RSko3MHJIcTlfWEl5Wk9ydndiaUpEeWV2OWp6XzdfeE1zTEt3Z1VHQ0FzMTZiUE81ZWh2QmphT3gtN0RrSzhBMUo0THljYW9abjRNc2ViT2toSQ?oc=5", "source_name": "TipRanks", "published_at": "2026-07-10T12:15:44+00:00", "published_display": "10 Jul 2026 12:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansoh Pharmaceutical Group Stock Sheds 4.2% in Hong Kong", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNYWtVZ1hFWC13dHJVNHY5ZGU0YVBVUnY4V1BsSE9lREptdHdxcWtvUkVvOG1teG1iemhfQXpjSlpLWko5dzFoMkxkSjNRYzd0SEwxcVpjdjJ1cnZleU9lalY4ZmVONDhic2c0QTFBek1kNHdOeHIwZWZ5TXJsNW1USm1SRlctUmZjT1RGYkg5M3YwWFRCSFZpSV9tZ0Faa3c?oc=5", "source_name": "Moomoo", "published_at": "2026-07-07T08:30:00+00:00", "published_display": "07 Jul 2026 08:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansoh Pharmaceutical Group (SEHK:3692) Wins Trial Approval, Is It Fully Priced?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-05T07:00:00+00:00", "published_display": "05 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Results: Hansoh Pharmaceutical Group Company Limited Beat Earnings Expectations And Analysts Now Have New Forecasts", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-AFBVV95cUxNS0ZQelVmQklyUFl2aGt3OUNWaU5CdVNSQlVheGs2TG1TWklzQ2syZlc5TUpfdmI0djZCc2hnT0U3eUROT3N1OWxEWmZYSHhRLW1maEthY19Eejdhd3pkYUNSbGctMy1KeVhEdjlpLU5VMGJ4SG9RSmpFc3BJaHhrbGJYb3cwVHQxZnVOTUM3QXpKNFZ6YmJQazFNWTJkTVAzT2JlWHhuSjlOcVV2M2dCUFVvbUNSSXk0WjI4Uzd1Y3VOTUxKNHFWaDRRNzBHVWh3TENVeUt3ZnlLendTX3JpZkxxc0tGSHFQOHhvVC1EU0hHV0htdU81RtIB_gFBVV95cUxNQThZS0kyaXR3YXRkWGY2U1M4REVCQ29HWkk5UmZWSGNfTkRBQ3ExWEhLbGQwa2xybGptcW9IVkNHMUdlaGV5OFFPa3FTT2tPcFZUVmhsVk1pRERzeDZKVVItUS1YQnFDcXpMMEhCbUZYSlg1SjRJYTd6ZUMwRFdPaXh5SlVFZGljQVhiRG1aSFVjZkpfMFR4eHVtc2xnZldEeUhQZDFWUW42UGRPdUdDVGI1QS15UkJySlg2ZGllZlhTTTBEU0RVTHlrd1RLcGxvcU0zUFRLVk9zc2MwM28zMmZQSU5jZnpoV1ZWaTFGaDc0Q19GOEZUWGFUTU5wQQ?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansoh and Leads Biolabs clinch US$2.5 billion in global drug licensing deals", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "South China Morning Post", "published_at": "2025-10-17T07:00:00+00:00", "published_display": "17 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotheus, Hansoh ink potential \u00a55B deal for new bispecific ADCs", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOcVZRRENYWF9Ld09GXzVFS1g5a0VfUHREMzhTSXp0SGVPZ3BIN2JiVjdpclFpZjdGQWh4eHZrekFzWW9FcnpwM3I0Q2VnTzUzTUNBc0hjenN1dVdOeTFtbzl3dEVYVnRqcHpTT2FyM3F3Zkg3bFNPNGVoS0tCUF9lMWY2RzR1eUhGcklRTjBGcjhBVHpfZnFhZ2NmYzRYVDhMM1U4MA?oc=5", "source_name": "BioWorld News", "published_at": "2024-03-18T07:00:00+00:00", "published_display": "18 Mar 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GSK signs $1B+ licensing deal with China\u2019s Hansoh for ADC candidate", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPTlAtN2gxQV9jaFVPZUE2R1didGFDQThMZHBzbnM2TmQ5YmhiUjNnUm15QWJ3T0N5MUgtaG5oM2ZoQXFJRHJ2NHRfMC1oTHZKMTZUdXdscW0zX1NmVFUzQVRBMmlIOEtMT1BrQ3BfX0dKdTJiM25BWU80d3FXOEhqV0JDTUZidDVYam9FRVZaejhLQXljMFFKTVZ1S2pzalBmYzVSeDhRVUg?oc=5", "source_name": "BioWorld News", "published_at": "2023-10-23T07:00:00+00:00", "published_display": "23 Oct 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hang Seng review shines light on China\u2019s 6th richest woman at Hansoh Pharma", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "South China Morning Post", "published_at": "2022-08-22T07:00:00+00:00", "published_display": "22 Aug 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of Hansoh Pharmaceutical Group Company Limited (HKEX:3692)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiaEFVX3lxTE0yaHNIOThuNmNEVnRVZmFrckg1dlQ2Q081RGxvSXdRckJkNmg0STJWZFhWTXgyeFN1aHBpUXBnZXZPc1ZINmFYNnZFOGpHUGl5SjV4V0hFMmVSSDE5UUVZY3pGYkNQakZE?oc=5", "source_name": "TradingView", "published_at": "2019-10-11T04:43:01+00:00", "published_display": "11 Oct 2019 04:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 69, "total_relevant": 10, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 8, "score": 54, "total": 10, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 2.75, "count": 5}, {"event": "deals", "label": "Deals and strategy", "weight": 1.65, "count": 3}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 31.94, "latest_week": "2026-07-10", "one_week_move": -5.2, "four_week_move": 7.2, "twelve_week_move": -19.7, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.627467, "market_dynamics_buy_signal": false, "relative_strength": -5.879448, "fair_value_gap": 36.3, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "negative", "expectation_probability": 43.7618, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-5.2% over one week, +7.2% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 62, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TipRanks", "count": 2}, {"label": "simplywall.st", "count": 2}, {"label": "South China Morning Post", "count": 2}, {"label": "BioWorld News", "count": 2}, {"label": "Moomoo", "count": 1}, {"label": "TradingView", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 10}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 5}, {"label": "Deals and strategy", "count": 3}, {"label": "Regulatory and legal", "count": 1}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "10", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-5.2% over one week, +7.2% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Hansoh Pharma Licenses IL-23 Drug to Avere and Gains Major Stake in Nasdaq-Bound Merger"}], "updated_at": "2026-07-17T18:47:27.565133+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}